Neal C Bradsher
CIK 1278388 · last filed 2026-03-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.01B
Companies
12
Total Filings
98
Lifetime Open-Market Net
$137.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STAA | Director | 31,016,786 | $28.37 | $879.95M | $107.63M | 32 | 2026-03-13 |
| LCTX | Director | 99,121,984 | $1.27 | $125.88M | $18.00M | 9 | 2025-07-03 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 54,558,508 | — | — | $10.50M | 23 | 2018-07-03 |
| BTX | 10%+ Owner | 0 | $9.03 | $0 | -$4.6K | 2 | 2017-09-18 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 6,113,360 | $3.20 | $19.56M | $0 | 1 | 2017-02-22 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | 7,399,696 | — | — | $0 | 1 | 2016-05-13 | |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 3,282,050 | — | — | $0 | 1 | 2015-05-26 | |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 5,478,320 | — | — | -$12.48M | 7 | 2014-01-31 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (METH.A) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2013-06-26 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,793,474 | — | — | $8.38M | 4 | 2012-11-16 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 1,533,937 | — | — | $5.18M | 12 | 2008-04-25 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | 3,578,660 | — | — | $323.4K | 3 | 2008-01-03 |
Recent Filings · Page 8 of 10
98 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-07-07 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-15 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | +3,300,000 | $0 | EDGAR |
| 2009-01-05 | QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-12-10 | STAA | Buy (P) | +889,581 | $1.52M | EDGAR |
| 2008-11-20 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | +68,277 | $0 | EDGAR |
| 2008-11-18 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Other (J) | −68,277 | $0 | EDGAR |
| 2008-04-25 | COMARCO INC (CMRO) Delisted | Buy (P) | +217,443 | $717.8K | EDGAR |
| 2008-01-04 | COMARCO INC (CMRO) Delisted | Buy (P) | +5,700 | $31.4K | EDGAR |
| 2008-01-03 | QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-12-28 | COMARCO INC (CMRO) Delisted | Buy (P) | +240,654 | $1.32M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.